Literature DB >> 16417249

Synthesis and evaluation of novel dendrimers with a hydrophilic interior as nanocarriers for drug delivery.

Renu Singh Dhanikula1, Patrice Hildgen.   

Abstract

Novel polyester-co-polyether dendrimers consisting of a hydrophilic core were synthesized by a combination of convergent and divergent syntheses. The core was synthesized from biocompatible moieties, butanetetracarboxylic acid and aspartic acid, and the dendrons from PEO (poly(ethylene oxide)), dihydroxybenzoic acid or gallic acid, and PEG monomethacrylate. The dendrimers, Den-1-(G 2) (second generation dendrimer-1) and Den-2-(G 2) (second generation dendrimer-2) consisting of 16 and 24 allyl surface groups, respectively, were obtained by coupling the dendrons to the core. The dendrimer (Den-1-(G 2)-OH) with hydroxyl groups at the surface was synthesized by oxidation of the allyl functional groups of Den-1-(G 2), which was divergently coupled to the dendrons to obtain the third generation dendrimer Den-1-(G 3) consisting of 32 surface groups. The modifications in surface groups and generation of dendrimers were shown to influence the shape of dendrimers in the AFM studies. The aggregation as well as self-assembly of dendrimers was observed at high concentration in water by light scattering studies; however, it was reduced on dilution and in the presence of sodium chloride. Dendrimers demonstrated good ability to encapsulate the guest molecule, with loading of 15.80 and 6.47% w/w for rhodamine and beta-carotene, respectively. UV spectroscopy proved the absence of any pi-pi complexation between the dendrimer and encapsulated compounds. (1)H NMR and FTIR studies showed that the physical entrapment and/or hydrogen bonding by PEO in the interior and branch of the dendrimer are the mechanisms of encapsulation. The release of the encapsulated compounds was found to be slow and sustained, suggesting that these dendrimers can serve as potential drug delivery vehicles.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16417249     DOI: 10.1021/bc050184c

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  5 in total

Review 1.  Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis.

Authors:  Hu Yang
Journal:  Pharm Res       Date:  2010-07-01       Impact factor: 4.200

Review 2.  Efficacy of Polymer-Based Nanomedicine for the Treatment of Brain Cancer.

Authors:  Tobeka Naki; Blessing A Aderibigbe
Journal:  Pharmaceutics       Date:  2022-05-13       Impact factor: 6.525

3.  Encapsulation of organic molecules in calcium phosphate nanocomposite particles for intracellular imaging and drug delivery.

Authors:  Thomas T Morgan; Hari S Muddana; Erhan I Altinoglu; Sarah M Rouse; Amra Tabaković; Tristan Tabouillot; Timothy J Russin; Sriram S Shanmugavelandy; Peter J Butler; Peter C Eklund; Jong K Yun; Mark Kester; James H Adair
Journal:  Nano Lett       Date:  2008-12       Impact factor: 11.189

4.  Dendrimer Nanodevices and Gallic Acid as Novel Strategies to Fight Chemoresistance in Neuroblastoma Cells.

Authors:  Silvana Alfei; Barbara Marengo; Guendalina Zuccari; Federica Turrini; Cinzia Domenicotti
Journal:  Nanomaterials (Basel)       Date:  2020-06-26       Impact factor: 5.076

Review 5.  The Role of Branch Cell Symmetry and Other Critical Nanoscale Design Parameters in the Determination of Dendrimer Encapsulation Properties.

Authors:  Donald A Tomalia; Linda S Nixon; David M Hedstrand
Journal:  Biomolecules       Date:  2020-04-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.